3EOA | Immune System Cell Adhesion | date | Sep 26, 2008 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure The Fab Fragment Of Efalizumab In Complex I Domain, Form I | ||||||||||||||
authors | S.Li, J.Ding | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Efalizumab Fab Fragment, Light Chain Chain: L, A Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_taxid: 9606 Gene: Igg1 | ||||||||||||||
Molecule: Efalizumab Fab Fragment, Heavy Chain Chain: H, B Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_taxid: 9606 Gene: Igg1 | ||||||||||||||
Molecule: Integrin Alpha-L Chain: I, J Fragment: I Domain Synonym: Leukocyte Adhesion Glycoprotein Lfa-1 Alpha Chain, Leukocyte Function-Associated Molecule 1 Alpha Chain, Cd11 Like Family Member A; Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Itgal, Cd11a Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Bl21(De3) Expression_system_vector_type: Plasmid Expression_system_plasmid: Pet32a | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.80 Å | ||||||||||||
Primary reference | Efalizumab binding to the LFA-1 alphaL I domain blocks ICAM-1 binding via steric hindrance., Li S, Wang H, Peng B, Zhang M, Zhang D, Hou S, Guo Y, Ding J, Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4349-54. Epub 2009 Mar 3. PMID:19258452 |
Data retrieval |
View 3EOA in 3D |
Visual 3D analysis of 3EOA |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3EOA |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |